期刊文献+

基本药物制度实施效果评价研究综述 被引量:19

Review on the effect evaluation of essential medicine system
暂未订购
导出
摘要 按照世界卫生组织对基本药物的定义,从可获得性、可负担性和合理用药三个方面,对国内外相关评估方法及指标进行综述,为基本药物制度效果评价研究提供方法学参考。世界卫生组织等国际机构对基本药物制度的效果评价提出了多维度的评价指南,为我国进行该方面研究提供了借鉴。目前我国基本药物可获得性研究多停留在描述性统计分析,可负担性研究较少涉及地域间的横向对比,对合理用药的评价尚不规范,基本药物制度效果评价亟需与国际多维度的分析框架和关键评价指标接轨,并关注政策执行过程与效果的结合,以展开系统而有效的政策评估。 In this paper, We summarize several evaluation methods at home and abroad that are based on the WTO division method of essential medicine, and provide references for empirical research of essential medicine. The division method capitalizes on the availability, affordability, and rational use of essential drugs. Vie conclude that WHO and other international organizations put forward multi-angle and multi-dimensional evaluation guides and pro- vide a good reference for China. However, most research in this field in China is focused on descriptive statistical a- nalysis. The limited range of the survey meant that this research did not have an adequate focus on the comparison between different places. To research the effects of implementing essential medicine, researchers have to rebuild an evaluation standard and widen their ideas on analysis in order to make evaluation valuable.
出处 《中国卫生政策研究》 CSCD 2013年第4期12-18,共7页 Chinese Journal of Health Policy
基金 中澳卫生与艾滋病项目"医药卫生体制改革评价研究"
关键词 基本药物 可获得性 可负担性 合理用药 Essential medicine Availability Affordability Rational use of drug
  • 相关文献

参考文献49

  • 1Quick J D, Hogerzeil HV, VelaAsquez G, et al. Perspeef- ives:Twenty--five years of essential medicines[R]. Bulleti-nor the World Health Organization, 2002, 80 (11): 913-914.
  • 2蒋舒.提高药品可及性的政策选择——强制许可[J].经济论坛,2004(12):122-123. 被引量:9
  • 3孙静.WHO基本药物概念与国家实践[J].中国卫生政策研究,2009,2(1):38-42. 被引量:33
  • 4WHO. How to investigate drug use in health facilities [ EB/ OL]. (2010-10-20) [2013-04-10]. http: //hinfo. hu- maninfo, ro/gsdldata/collect/medicinedocs/pdtYs2289 e! s2289e, pdf.
  • 5WHO. WHO Medicines Strategy (2008--2013) (draft) [ M ]. Geneva : World Health Organization, 2008.
  • 6WHO. A practical manual- Indicators for monitoring national drug policies[ EB/OL]. [ 2013-04-10] http://whqlibdoc. who. int/hq/1999/WHO _ EDM _ PAR _ 99. 3 _ pp115- 226. pdf.
  • 7WHO. WHO/Health Action International Project on Medi- cine Prices and Availability[ EB/OL]. [ 2013-04-10 ]. http ://www. who. int/medicines/areas/access/Medicine _ Prices and Availability/err/.
  • 8WHO. How to investigate the use of medicines by consumers [ EB/OL]. [ 2013-04-10]. http://whqlibdoc, who. int/hq/ 2004/WHO_EDM_PAR_2004.2. pdf.
  • 9Islam, M.. Health Systems Assessment Approach: A How- To Manual [ R ]. Arlington, VA : Management Sciences for Health, 2007.
  • 10i USAID. Health Governance: Concepts, Experience, and Programming Options. Policy brief. Bethesda [ R ]. MD : Abt Associates, Health Systems, 2008.

二级参考文献148

共引文献239

同被引文献183

引证文献19

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部